The innate immune system recognizes key molecular signatures of pathogens or pathogen-associated molecular patterns that include structural components such as lipopolysaccharide (LPS) and peptidoglycan, as well as double-stranded RNA (dsRNA) and dsDNA. Recognition of pathogen-associated molecular patterns by the host organism occurs through a group of receptors referred to as pathogenrecognition receptors, the best-studied of which are the Toll-like receptors (TLRs) 1 . The cytoplasmic domains of TLRs contain a Toll-interleukin 1 receptor (IL-1R) homology domain (TIR domain) that forms a platform for downstream signaling by recruiting TIR domain-containing adapters, including MyD88 (A003535), TIRAP and TRIF 2,3 . Engagement of TLR-proximal signaling complexes leads to a sequential cascade of transcriptional regulatory events that vary depending on the TLR agonists, cell types involved and pathogenicity of the microbe. Individual genes (notably those encoding proinflammatory cytokines) are induced transiently and then are repressed, which reflects the ability of the innate immune system to interpret the infection and orchestrate appropriate responses while promoting resolution [4] [5] [6] . Microbial products are not the only signals that modulate innate immune responses, as signals produced by stressed or damaged tissues have also been suggested to modulate the inflammatory response 7-9 .
The innate immune system recognizes key molecular signatures of pathogens or pathogen-associated molecular patterns that include structural components such as lipopolysaccharide (LPS) and peptidoglycan, as well as double-stranded RNA (dsRNA) and dsDNA. Recognition of pathogen-associated molecular patterns by the host organism occurs through a group of receptors referred to as pathogenrecognition receptors, the best-studied of which are the Toll-like receptors (TLRs) 1 . The cytoplasmic domains of TLRs contain a Toll-interleukin 1 receptor (IL-1R) homology domain (TIR domain) that forms a platform for downstream signaling by recruiting TIR domain-containing adapters, including MyD88 (A003535), TIRAP and TRIF 2, 3 . Engagement of TLR-proximal signaling complexes leads to a sequential cascade of transcriptional regulatory events that vary depending on the TLR agonists, cell types involved and pathogenicity of the microbe. Individual genes (notably those encoding proinflammatory cytokines) are induced transiently and then are repressed, which reflects the ability of the innate immune system to interpret the infection and orchestrate appropriate responses while promoting resolution [4] [5] [6] . Microbial products are not the only signals that modulate innate immune responses, as signals produced by stressed or damaged tissues have also been suggested to modulate the inflammatory response [7] [8] [9] .
The endoplasmic reticulum (ER) stress response identifies a group of signals that cope with perturbations in ER homeostasis. This adaptive response activates two parallel kinases (IRE1 (A003134) and PERK) and a transcription factor precursor (ATF6) that instigate distinct signaling pathways 10 . The most conserved signaling branch consists of IRE1, an ER-anchored kinase that functions by activating the transcription factor XBP1. The XBP1 mRNA encodes a nonfunctional protein that is activated by an IRE1-dependent unconventional cytosolic mRNA-splicing event that generates a mature (spliced) XBP1 protein (XBP1s) with a potent transactivation domain. Although all three branches are activated simultaneously, the responses set in motion by IRE1 are rapidly attenuated despite the persistence of stress, whereas those downstream of PERK activation are sustained. That observation has led to the suggestion that IRE1 and XBP1 function to facilitate homeostasis in the adaptation phase of the response, whereas PERK activation may favor cell death through its downstream transcription factor CHOP 11 .
Large-scale gene-expression studies have reported transcriptional induction of the XBP1 mRNA precursor after TLR stimulation 5 and after infection of human macrophages or mouse lung tissues with pathogenic Mycobacteria and Klebsiella pneumoniae species [12] [13] [14] . Although those studies did not investigate the maturation of XBP1 mRNA, they demonstrated that the IRE1 substrate is produced after TLR stimulation. Some ER-stress markers have also been detected after sustained LPS stimulation [15] [16] [17] . In the liver, for example, the ER-stress response has been shown to promote inflammation by upregulating expression of acute-phase proteins 17 . Together, these observations prompted us to investigate a possible link between ER signaling and innate immunity.
Here we identify a previously unknown function of the XBP1 branch of the ER-stress pathway as a positive regulator of TLR responses in macrophages. We show that TLRs engaged IRE1α to promote cytosolic splicing and activation of XBP1. Activation of IRE1α and XBP1 by TLRs occurred in the absence of an ER-stress response and did not contribute to the induction of ER stress-induced genes. Instead, activation of XBP1 by IRE1 was needed to promote sustained production of inflammatory mediators, including IL-6, which demonstrates that a specific branch of the ER-stress response can operate 4 1 2 VOLUME 11 NUMBER 5 MAY 2010 nature immunology A r t i c l e s independently of the other branches. Consistent with a positive function for XBP1 in TLR responses, more production of active XBP1 by macrophages with pharmacologically induced ER stress exacerbated TLR responses. Moreover, XBP1-deficient mice infected with F. tularensis live vaccine strain (LVS) had a greater bacterial burden and less production of inflammatory mediators.
RESULTS

TLRs trigger XBP1 activation in macrophages
We tested whether TLRs might activate the ER-stress response. We stimulated mouse J774 macrophages with the TLR4 agonist LPS and analyzed activation of IRE1α, PERK and ATF6α. We measured activation of ATF6α by monitoring the liberation of its cleaved fragment and measured activation of PERK and IRE1α by examining their phosphorylation status. To detect active IRE1α, we used the Phostag reagent, which selectively binds to phosphorylated amino acid residues 18, 19 . In polyacrylamide gels containing Phos-tag acrylamide, we detected phosphorylated forms of IRE1α by slower migration after stimulation with LPS (Fig. 1a) . However, we did not detect activation of ATF6α or PERK (Fig. 1a) . To further examine the effects of TLR signaling on the classical ER-stress response, we stimulated cells with tunicamycin, a potent pharmacologic ER-stress inducer, in the presence or absence of LPS or Pam 3 CSK 4 , a TLR2 agonist. Tunicamycin alone induced activation of the ER-stress response, as expected. Despite IRE1α activation, we found that LPS or Pam 3 CSK 4 did not induce a classic ER-stress response 10 , as measured by expression of CHOP, the ER chaperones BiP and ERdj4, and the disulfide isomerase PDI. In fact, treatment with both LPS and Pam 3 CSK 4 repressed ER stress-induced mRNA, including CHOP, PDI and ERdj4, and the proteolytic processing of ATF6α triggered by treatment of J774 macrophages with tunicamycin ( Fig. 1b  and Supplementary Fig. 1a) . Similar to the results obtained in costimulation experiments, prestimulation of macrophages with TLR agonists substantially inhibited the tunicamycin-mediated activation of PERK and ATF6 as well as the production of CHOP or PDI mRNA (Supplementary Fig. 1b,c) . Moreover, short-term stimulation with LPS or Pam 3 CSK 4 inhibited ER stress-induced genes in macrophages pretreated with tunicamycin ( Supplementary Fig. 1d) . Notably, tunicamycin-mediated recruitment of XBP1s to the promoter of Dnajb9 (which encodes ERdj4) was lower in the presence of LPS (Supplementary Fig. 1e ), which further demonstrated that TLR4 signaling blocks ER-stress responses. By analyzing primary macrophages from MyD88-deficient mice, we observed that dampening of the ER-stress response by TLR2 (Pam 3 CSK 4 ) was MyD88 dependent, whereas dampening by TLR4 was only partially dependent on MyD88 (Supplementary Fig. 1f ). We conclude that TLR2 and TLR4 trigger IRE1α activation while inhibiting the ER-stress response.
BiP mRNA (relative) As TLR signaling did not induce the expression of known XBP1 target genes, we sought to determine whether TLRs activate splicing of XBP1 mRNA. IRE1α-mediated splicing of XBP1 mRNA generates XBP1s, a potent transcriptional activator. We detected splicing of XBP1 mRNA and production of XBP1s protein as early as 3 h after LPS stimulation (Fig. 1c) . As reported above, we did not detect CHOP or ATF6α, two transcription factors that are induced or activated after ER stress, after TLR stimulation. Investigation of a panel of TLR agonists showed that agonists that engage TLR2, TLR4 and TLR5, but not those that engage TLR3, TLR7 or TLR9, promoted XBP1 splicing (Fig. 1d) . The production of XBP1s after stimulation with TLR4 and TLR2 was IRE1α dependent, as demonstrated by defective LPS-or Pam 3 CSK 4 -induced splicing of XBP1 mRNA in cells expressing IRE1α-specific short hairpin RNA (shRNA; Fig. 1e ). We also observed TLR activation of XBP1 in primary macrophages from wild-type mice (C3H/HeOuJ) after LPS stimulation. Macrophages isolated from mice carrying a mutation in sequence encoding the signaling domain of TLR4 (C3H/HeJ mice) did not activate XBP1 after LPS stimulation (Fig. 1f) . Similarly, the TLR2 agonists Pam 3 CSK 4 and FSL1 did not activate XBP1 splicing in TLR2-deficient macrophages ( Supplementary Fig. 2 ), which demonstrated that XBP1 splicing was triggered by TLRs rather than by a potential direct effect of these pathogen-associated molecular patterns on the ER.
TLR activation of XBP1 is NOX2 NADPH oxidase dependent
To identify the downstream effectors of TLRs that mediate XBP1 activation, we investigated XBP1 splicing in macrophages from mice deficient in MyD88, TRIF or TIRAP. TLR2-induced splicing of XBP1 was dependent on the TIRAP-MyD88 signaling pathway, whereas deficiency in TRIF or MyD88 only partially inhibited TLR4 activation of XBP1 (Fig. 2a) , which suggested that both MyD88-dependent signaling and MyD88-independent (TRIF-dependent) signaling lead to TLR4-induced splicing of XBP1. Both TRIF and MyD88 are known to engage the signaling molecule TRAF6 (A002312) and the downstream transcription factor NF-κB scaffolding protein NEMO 2 . Analysis of J774 macrophage populations stably expressing shRNA targeting TRAF6 or NEMO showed that TRAF6 was required for XBP1 splicing mediated by TLR2 and TLR4; in contrast, NEMO was dispensable (Fig. 2b) . As a control, populations in which NEMO or TRAF6 was knocked down failed to induce Il6 transcription after LPS stimulation (Fig. 2b) and did not affect tunicamycin-mediated activation of XBP1 mRNA (Supplementary Fig. 3a) . Further, pharmacological inhibition of the pathways of NF-κB, the mitogenactivated protein kinase p38, c-Jun N-terminal kinase (Jnk) and mitogen-activated protein kinase kinase did not affect LPS-induced XBP1 splicing ( Supplementary Fig. 3b ), which confirmed that splicing is mediated by TRAF6 activation independently of the NF-κB, p38 and Jnk pathways.
TRAF proteins can bind and activate NADPH oxidase, a membrane-bound enzyme complex found in the plasma membrane as well as in phagosome membranes [20] [21] [22] . The NADPH oxidase NOX2 (A002484) mediates the induction of reactive oxygen species (ROS) by TLRs in macrophages 23 . Use of the NADPH oxidase inhibitors diphenyleneiodonium chloride and apocynin, as well as NOX2 deficiency, abolished splicing of XBP1 by LPS or Pam 3 CSK 4 but not splicing of XBP1 by tunicamycin treatment (Fig. 2c,d ), which demonstrates that TLR4 and TLR2 mediate XBP1 splicing by activating the NADPH oxidase complex. Notably, oxidative stress has been shown to promote ER stress 24 ; however, pretreatment with chemical chaperones that alleviate mild ER stress did not affect XBP1 activation further (Supplementary Fig. 3c ). These data suggest that TLRs and NOX2 engage a specific IRE1-activating pathway.
TLR activation of XBP1 regulates cytokine production
To establish the function of XBP1 in TLR signaling, we used Xbp1 flox/floxMxCre mice (called 'XBP1 ∆ mice' here), which lack XBP1 in macrophages and other cells of the hematopoietic lineage 25 . Consistent with the results presented above, we observed no induction of classic ER stress-related genes, such as those encoding CHOP or PDI, after stimulation of XBP1 ∆ or wild-type macrophages with LPS. As control, tunicamycin induction of PDI and WSF1 was lower in XBP1 ∆ macrophages ( Supplementary Fig. 4) , indicative of efficient XBP1 deletion. 
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However, XBP1 ∆ macrophages stimulated with TLR4 or TLR2 agonists showed impaired secretion of IL-6, as measured by enzyme-linked immunosorbent assay (ELISA; Fig. 3a) , and impaired production of other inflammatory mediators, including tumor necrosis factor (TNF), interferon-β (IFN-β), the ubiquitin-like modifier ISG15 and cyclooxygenase 2, in addition to IL-6, as measured by quantitative RT-PCR (Fig. 3b) . The defect was specific to certain mediators, as other cytokines, such as IL-1β and RANTES, were unaffected by XBP1 deficiency (Fig. 3b) . Notably, XBP1 ∆ macrophages did not show an absolute defect; instead, we found that early IL-6 mRNA induction (at 1 h) was similar to that in wild-type cells, but that IL-6 mRNA production was defective at later time points (6 h; Fig. 3c) . Consistent with the unperturbed early cytokine profile, early induction of degradation of the NF-κB inhibitor IκBβ, Jnk phosphorylation and macrophage viability were not affected (Supplementary Fig. 5) . Together these findings demonstrate that XBP1 in macrophages is required downstream of TLR2 and TLR4 for sustained production of innate immune mediators such as IL-6.
XBP1 activation by ER stress enhances TLR signaling
The experiments presented above suggested that activation of the IRE1-XBP1 signaling pathway by the innate immune system in macrophages is required for optimal secretion of certain proinflammatory cytokines. We sought to determine whether augmenting this pathway through pharmacologic induction of an ER-stress response would enhance the natural response to microbial products. Indeed, LPS treatment increased tunicamycin-induced splicing of XBP1, but not in TLR4-unresponsive macrophages (Fig. 1f) . Notably, the amount of IL-6 and ISG15 produced by LPS-stimulated macrophages was synergistically increased in cells simultaneously treated with tunicamycin (Fig. 4a) . To demonstrate that this effect was triggered by IRE1α, we transduced J774 macrophages with a constitutively active recombinant protein encoding the cytosolic kinase and RNase domains of IRE1α 26 . We observed much more IL-6 production in the presence of active IRE1α and LPS (Fig. 4b) . Similarly, knockdown of BI-1, an ER-localized negative regulator of IRE1α 26 , mediated more XBP1 activation and more IL-6 production after LPS treatment ( Supplementary  Fig. 6 ). In confirmation of those results, knockdown of IRE1α in J774 macrophages resulted in less IL-6 induction by cotreatment with tunicamycin and LPS (Fig. 4c) . Notably, we confirmed that finding in primary wild-type and XBP1 ∆ macrophages left untreated or pretreated for 16 h with a low dose of tunicamycin and then stimulated for 3 h with LPS. Wild-type but not XBP1 ∆ macrophages showed augmented IL-6 production (Fig. 4d) . We also determined whether this newly identified pathway of XBP1 activation by TLRs alone and in concert with ER stressors was operative in human cells. Primary human macrophages infected with F. tularensis LVS showed more XBP1 splicing and a synergistic enhancement in cytokine production with the addition of tunicamycin. Specifically, the production of IL-6, TNF and IL-8 after infection with F. tularensis was considerably enhanced in the presence of tunicamycin (Fig. 4e) .
We sought to determine whether some or all genes encoding these cytokines are direct XBP1 targets. Chromatin-immunoprecipitation (ChIP) experiments showed substantial recruitment of XBP1 to the promoters of genes encoding some inflammatory mediators, including Il6 and Tnf, but not Il1b or Ccl5, which encodes RANTES (Fig. 5  and Supplementary Fig. 7 ). These data suggest that XBP1 may contribute directly to the transcription of genes encoding at least some of these inflammatory cytokines.
XBP1 is required for immune responses to F. tularensis
To test the function of XBP1 in the handling of pathogens in vitro, we infected wild-type primary macrophages with three different pathogens that are agonists for TLR2 and/or TLR4: Mycobacterium tuberculosis, Listeria monocytogenes and F. tularensis. Infection with any of these pathogens induced spliced XBP1 mRNA (Fig. 6a) . We next investigated the physiological relevance of those observations in the context of infection with F. tularensis. The immune response to this intracellular bacterium and potential bioterrorism agent that causes the human disease tularemia has been studied in mice through use of the LVS strain 27 . Optimal immunity to 
F. tularensis requires TLR2 (refs. 28-30
) and the secretion of cytokines, including TNF, by macrophages 31 . Consistent with the observation that TLR2 is the main TLR activated by F. tularensis, we found that F. tularensis-mediated splicing of XBP1 was deficient in Tlr2 −/− macrophages (Fig. 6b) . Similarly, NOX2 deficiency impaired XBP1 activation after infection with F. tularensis (Fig. 6b) . We infected bone marrow-derived macrophages (BMMs) from Tlr2 −/− , NOX2-deficient (Cybb −/− ), XBP1 ∆ and wild-type mice with F. tularensis LVS and monitored the production of inflammatory mediators by real-time PCR. TLR2 deficiency severely impaired cytokine production induced by F. tularensis, whereas optimum induction of IL-6 and TNF was dependent on NOX2 and XBP1 ( Fig. 6c and Supplementary Fig. 8a ). In contrast, greater production of IL-1β was independent of XBP1 and NOX2 (Fig. 6c) .
To confirm that XBP1 potentiates F. tularensis-mediated cytokine production, we infected BMMs from XBP1 ∆ and wild-type mice in the presence or absence of tunicamycin. Consistent with the data obtained with TLR agonists (Fig. 3d) , we found that XBP1 was required for maximum synergistic induction of IL-6 in infected macrophages (Fig. 6d) . TLR2 deficiency has been shown to result in less production of IL-6 and TNF in vivo and a greater bacterial load in F. tularensis-infected mice 32, 33 . To test whether loss of XBP1 impaired the immune response to F. tularensis in vivo, we infected wild-type and XBP1 ∆ BALB/c mice with low doses of F. tularensis by aerosol exposure, a mimic of the often lethal human disease pneumonic tularemia. The survival of XBP1 ∆ and wild-type mice was not impaired substantially. However, similar to TLR2-deficient mice, at 7 d after aerosol infection, XBP1 ∆ mice had a bacterial burden in the spleen, lung and liver that was over one log higher than that of their wild-type littermates (Fig. 6e) . By day 14, both wild-type and XBP1 ∆ mice had cleared the infection, as determined by the absence of bacteria in the spleen and liver, although XBP1 ∆ lungs had significantly greater bacterial loads than did wild-type lungs, even at day 14 (Fig. 6f) . Consistent with the greater bacterial burden, histopathology showed more nondiscrete neutrophil-rich granulomatous lesions in XBP1 ∆ liver than in wild-type liver at day 7 after infection ( Supplementary  Fig. 8b ). Hence, XBP1 is involved in the early protective host innate immune response to infection with F. tularensis but is probably not important in the adaptive immune response to this organism. That is consistent with our finding that XBP1 splicing is not evident in T cells (unpublished data) and published observations that B cells are not important in the early response to natural infection with F. tularensis 34 . 
DISCUSSION
Similarities in signaling pathways stemming from TLR and ER-stress receptors have been noted 35 . Both IRE1α and TLRs trigger the production of ROS and acute-phase proteins and both engage NEMO and TRAF adaptors to trigger inflammatory signaling components such as NF-κB and Jnk 2,36,37 . Such similarities suggest that these pathways may have coevolved common strategies to respond to specific insults. Our findings here have demonstrated that TLR and IRE1-XBP1 pathways are interconnected and act together to maximize innate immune responses to pathogens. We have shown that XBP1 mRNA was matured to its active form by TLR4 and TLR2 via a mechanism that required the NADPH oxidase NOX2 together with TRAF6. Using NADPH oxidase inhibitors and NOX2-deficient macrophages, we have shown that TLR activation of XBP1 required ROS. Other pathways have been shown to trigger aspects of the ER-stress response in an ROS-dependent manner 24 . TNF treatment, for example, promotes the activation of PERK, ATF6α and IRE1 in a ROS-dependent way, whereas ROS production by arsenite activates the phosphorylation of eIF2α but not of PERK or IRE1α, which indicates that different oxidative stresses selectively activate different downstream pathways 38 . In the case of TLRs, we observed a nontraditional and specific activation of the IRE1-XBP1 pathway.
Unexpectedly, the function of the IRE1-XBP1 pathway in macrophages that we identified here was independent of ER stress. We found that TLR4 and TLR2 stimulation triggered phosphorylation of IRE1 and maturation of XBP1 mRNA in the absence of any other ER-stress markers, such as processing of ATF6α, phosphorylation of PERK or induction of ER stress-dependent genes encoding CHOP, BiP, ERdj4 and PDI. Consistent with a published report describing that prolonged stimulation with low doses of LPS inhibits ER stress-mediated ATF4 activation and CHOP induction 39 , we found similar inhibition in macrophages. Moreover, we observed that in macrophages, ER-stress inhibition occurred very rapidly after activation of TLR2 and TLR4 and affected all the branches of the ER-stress response. The ATF6α and PERK branches were inhibited, as was expression of known XBP1 target genes such as the gene encoding ERdj4. These findings demonstrate that TLR signaling broadly regulates ER-stress responses and provide some rationale for why TLR2 and TLR4 do not trigger known XBP1 and ER stress-dependent genes, despite activation of IRE1 and XBP1. Because of the complex and cooperative nature of the ER-stress response, it is likely that deficiency in the activation of ATF6α and PERK contributes to the absence of upregulation of genes normally induced by ER stress. Having established that XBP1 activation downstream of TLR2 and TLR4 did not contribute to an ER-stress response, we investigated the role of XBP1 in regulating TLR responses.
Certain transcription factors can modulate the amplitude and nature of innate immune responses via feedback loops that allow 'fine tuning' of transcriptional programs appropriate to a given host-pathogen interaction 5 . For example, ATF3 (ref. 6 ) and IRF4 (refs. 40,41) negatively regulate TLR4 signaling, whereas C/EBPδ was identified as an amplifier of TLR-induced signals 42 . Here we have identified XBP1 as a regulatory factor that enhances cytokine production via TLR2 and TLR4. We have provided several lines of evidence indicating that XBP1 functions in a positive feedback loop to sustain TLR signaling in macrophages. First, TLR2 and TLR4 signaling from the plasma membrane activated IRE1α to promote the maturation of XBP1 mRNA and production of active XBP1s protein. Second, XBP1 deficiency in macrophages impaired sustained production of specific cytokines, including IL-6 and IFN-β, after stimulation with TLR agonists or infection with F. tularensis without affecting early production of these cytokines. Third, consistent with the hypothesis that XBP1 enhanced gene transcription, pharmacological activation of XBP1 synergistically augmented LPS-induced production of IL-6. That finding is consistent with a report showing that a RAW267.4 mouse macrophage cell line overexpressing XBP1s or stimulated with the ER-stress inducer thapsigargin produces more IFN-β after stimulation with LPS 43 . Finally, we have shown by in vivo experiments in mice that XBP1 was important for early responses to aerosol infection with F. tularensis. Notably, XBP1 is critical for the survival of Caenorhabditis elegans infected with pathogenic bacteria expressing pore-formin toxins, which suggests that its role in innate immunity has evolved through evolution 44 .
We used ChIP to show that XBP1 was recruited to the Il6 and Tnf promoters. XBP1 itself was insufficient to trigger substantially more production of IL-6 or TNF in macrophages in which the ER-stress response was triggered. Indeed, XBP1 activation acted in synergy with TLR signaling to activate the Il6 and Tnf promoters, which suggested that the mechanisms by which XBP1 regulates ER stress-responsive genes and the genes involved in the inflammatory response may differ. HAC1, the yeast XBP1 homolog, has been shown to regulate ERstress responses by directly binding ER stress-responsive elements at the promoter of target genes. However, HAC1 has also been shown to regulate early meiotic gene differentiation and responses to nitrogen starvation indirectly by binding the histone deacetylase complex 45 . It is therefore possible that in mammals, XBP1 may also regulate non-ER stress-related gene expression by orchestrating chromatin modification or other transcriptional regulatory elements at specific promoters.
The finding that macrophages with ER stress were hyper-responsive to TLR stimulation in an XBP1-dependent manner (as shown by the phenotype of XBP1-deficient macrophages) supports the idea that XBP1 is a positive regulator of TLR gene induction. It also supports the idea that ER stress itself may promote inflammation by regulating the intensity and duration of innate responses. In line with that hypothesis, it has been shown that ER stress caused by HLA-B27 misfolding enhances IL-23 production in a rat model of spondyloarthritis 46 . Because some diseases such as atherosclerosis, cystic fibrosis, inflammatory bowel disease and type 2 diabetes are characterized by features of both ER stress and inflammation [47] [48] [49] , it will be useful to determine whether ER stress (and XBP1 activation) is a major hallmark of tissue malfunction and damage that contributes to chronic low-grade inflammation and hyper-inflammatory responses to inflammatory stimuli by further exacerbating TLR-driven responses. Moreover, the development of pharmacological inhibitors of the IRE1-XBP1 pathway could present a new therapeutic strategy aimed at diminishing harmful TLR-mediated inflammation, whereas activators of this pathway may enhance innate immunity in the setting of vaccination or natural infection.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureimmunology/.
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